James Stambaugh, VP Clinical Affairs at Intersect ENT, Inc. (XENT), sold 4,000 shares at $16.00 ($64K) on 2016-09-06, disclosed to the SEC on 2016-09-07.
Open-market sale of $64k XENT by VP Clinical Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.00 | 300 | $5K | 7.5% |
| 2 | $16.00 | 3,700 | $59K | 92.5% |
| Total | $16.00 avg | 4,000 | $64K | 100% |
| Filing → |
| XENT | SELL | 2016-06-14 | $7K | — | Filing → |
| XENT | SELL | 2015-07-21 | $366K | — | Filing → |
| XENT | SELL | 2015-05-11 | $66K | — | Filing → |